Fedha

Beta
Hisa unazofuatilia
Sekta za hisa
Alama
Alama
Bei
Tofauti
Tofauti ya asilimia
Mwenendo wa data
Bei ya Awali
Fungua
Juu
Chini
Kiasi cha mauzo ya hisa
Mtaji wa Soko
SIXB
Materials
SIXB
Materials
SIXB
+0.25%
1,104.10
+2.73
+0.25%
1,101.371,103.631,105.311,091.41
SIXC
Communications
SIXC
Communications
SIXC
-1.50%
604.16
-9.19
-1.50%
613.35613.35613.35601.49
SIXE
Energy
SIXE
Energy
SIXE
-0.09%
1,197.81
-1.02
-0.09%
1,198.831,199.681,199.751,182.41
SIXI
Industrials
SIXI
Industrials
SIXI
-0.88%
1,740.41
-15.54
-0.88%
1,755.951,754.061,756.031,734.69
SIXM
Financials
SIXM
Financials
SIXM
-0.64%
634.44
-4.07
-0.64%
638.51637.41637.41633.05
SIXR
Staples
SIXR
Staples
SIXR
-0.31%
840.90
-2.62
-0.31%
843.52843.35846.40837.93
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0.38%
215.13
-0.82
-0.38%
215.95215.95216.84215.06
SIXT
Technology
SIXT
Technology
SIXT
+2.86%
3,228.71
+89.80
+2.86%
3,138.913,189.303,230.853,174.76
SIXU
Utilities
SIXU
Utilities
SIXU
+0.16%
935.87
+1.50
+0.16%
934.37934.72938.26927.50
SIXV
Health care
SIXV
Health care
SIXV
-1.37%
1,457.12
-20.31
-1.37%
1,477.431,474.121,474.121,451.80
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0.83%
2,399.84
+19.65
+0.83%
2,380.192,389.342,403.042,380.47
CRSP:NASDAQ
Crispr Therapeutics AG
US$ 48.78
-11.59%
(-6.40) Siku 1
US$ 50.05
+2.59% (+1.26)
Baada ya saa
Imefungwa: 24 Apr, 16:00:01 GMT -4  ·   USD
Alama zote
AlamaBeiTofautiTofauti ya asilimia
Inatayarisha maarifa maarufu ya CRSP...
Fungua
US$ 55.01
Juu
US$ 55.18
Chini
US$ 48.77
Mtaji wa soko
4.70B
Wastani wa kiasi cha mauzo
2.13M
Kiasi cha mauzo ya hisa
3.85M
Juu kwa wiki 52
US$ 78.48
Chini kwa wiki 52
US$ 33.03
EPS
-US$ 6.47
Beta
1.32
Hisa za wawekezaji
96.39M
Idadi ya wafanyakazi
393
Habari
Kutoka kwenye vyanzo vya wavuti
Wasifu
CRISPR Therapeutics AG is a Swiss–American biotechnology company headquartered in Zug, Switzerland. The company does business as CRISPR Therapeutics, Inc. in the United States. It was one of the first companies formed to utilize the CRISPR gene editing platform to develop medicines for the treatment of various rare and common diseases. The company has approximately 500 employees and has offices in Zug, Switzerland, Boston, Massachusetts, San Francisco, California and London, United Kingdom. Its manufacturing facility in Framingham, Massachusetts won the Facilities of the Year Award award in 2022. The company’s lead program, exagamglogene autotemcel, or exa-cel, was granted regulatory approval by the US Food and Drug Administration in December 2023. Wikipedia
Kuhusu Crispr Therapeutics AG
Afisa Mkuu Mtendaji (CEO)Samarth Kulkarni
Wafanyakazi393
Lilianzishwa2013
Makao makuuZug, Jimbo la Zug, Uswisi
Sekta-
Ripoti za awaliThamani zote katika USD
Loading Previous Earnings...
Taarifa ya mapato
Mapato
Mapato halisi
Thamani zote katika USD
Mac 2025
Jun 2025
Sep 2025
Des 2025
Mapato
elfu 865.00
elfu 892.00
elfu 889.00
elfu 864.00
Gharama ya bidhaa zilizouzwa
129.99M
115.05M
116.02M
137.23M
Gharama ya mapato
129.99M
115.05M
116.02M
137.23M
Gharama za utafiti na maendeleo
-
-
-
-
Jumla ya gharama za utafiti na maendeleo
-
-
-
-
Gharama za uuzaji, za jumla na za usimamizi
19.30M
18.92M
16.93M
18.40M
Gharama ya uendeshaji
19.30M
18.92M
16.93M
18.40M
Jumla ya gharama za uendeshaji
149.29M
133.96M
132.95M
155.63M
Mapato ya uendeshaji
-148.42M
-133.07M
-132.06M
-154.76M
Mapato mengine yasiyo ya uendeshaji
13.54M
22.07M
26.24M
24.76M
EBT ikijumuisha vipengee visivyo vya kawaida
-134.89M
-207.26M
-105.82M
-130.00M
EBT bila kujumuisha vipengee visivyo vya kawaida
-134.89M
-111.00M
-105.82M
-130.00M
Gharama ya kodi ya mapato
1.11M
1.29M
elfu 619.00
elfu 614.00
Kiwango cha kodi kinachotumika
-0.82%
-0.62%
-0.58%
-0.47%
Gharama nyingine za uendeshaji
-
-
-
-
Mapato halisi
-136.00M
-208.55M
-106.44M
-130.61M
Kiwango cha faida halisi
-15,722.08%
-23,379.93%
-11,973.12%
-15,117.25%
Mapato kwa kila hisa
-1.58
-1.29
-1.17
-1.37
Mapato ya riba na uwekezaji
-
-
-
-
Gharama ya riba
-
-
-
-
Jumla ya gharama halisi za riba
-
-
-
-
Gharama za kushuka kwa thamani na za kulipa deni
-
-
-
-
Mapato ya kampuni kabla ya riba, kodi, kushuka thamani na kulipa madeni
-143.69M
-128.42M
-127.63M
-149.10M
Faida au hasara kutokana na uuzaji wa vipengee
-
-
-
-
Maudhui yaliyotayarishwa kwa AI yanaweza kuwa na makosa. Pata maelezo zaidi

Utafiti

Majukumu yangu
Bado hujaanzisha jukumu lolote
Majukumu yako yataonekana hapa. Ratibu majukumu na uruhusu Google Finance ifanye kazi ukiwa mbali.
Violezo
Muhtasari wa hisa unazofuatilia
Uchanganuzi wa kila siku wa kabla ya soko kufunguliwa wa orodha ya hisa unazofuatilia
Mapato Yajayo
Ripoti za mapato yajayo katika wiki
Mabadiliko ya Bei na Kiasi cha Hisa Kisicho cha Kawaida
Onyo la mapema kuhusu mabadiliko ya kiwango cha miamala leo
Maudhui yaliyotayarishwa kwa AI yanaweza kuwa na makosa. Pata maelezo zaidi